MNA
DGX icon

Manning & Napier Advisors’s Quest Diagnostics DGX Stock Holding History

Manning & Napier Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$779K Sell
3,663
-13,633
-79% -$2.68M 0.01% 253
2026
Q1 		$3.41M Sell
17,296
-1,167
-6% -$227K 0.05% 186
2025
Q4 		$3.24M Sell
18,463
-1,793
-9% -$326K 0.04% 178
2025
Q3 		$3.86M Sell
20,256
-11,341
-36% -$2.01M 0.05% 172
2025
Q2 		$5.68M Buy
31,597
+8,720
+38% +$1.51M 0.07% 163
2025
Q1 		$3.87M Sell
22,877
-2,823
-11% -$464K 0.05% 187
2024
Q4 		$3.88M Sell
25,700
-2,789
-10% -$434K 0.04% 180
2024
Q3 		$4.42M Sell
28,489
-9,982
-26% -$1.49M 0.05% 196
2024
Q2 		$5.27M Buy
+38,471
New +$5.27M 0.06% 173
2017
Q2 		– Sell
-7,625
Closed -$748K – 322
2017
Q1 		$748K Hold
7,625
– – 0.01% 319
2016
Q4 		$700K Buy
+7,625
New +$657K ﹤0.01% 322
2015
Q2 		– Sell
-195,674
Closed -$15M – 360
2015
Q1 		$15M Hold
195,674
– – 0.07% 133
2014
Q4 		$13.1M Hold
195,674
– – 0.06% 145
2014
Q3 		$11.9M Buy
195,674
+2,250
+1% +$139K 0.05% 152
2014
Q2 		$11.3M Buy
193,424
+1,934
+1% +$113K 0.04% 158
2014
Q1 		$11.1M Buy
+191,490
New +$10.3M 0.05% 163

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Manning & Napier Advisors's DGX Position: Q2 2026 in Review

Manning & Napier Advisors reduced its Quest Diagnostics (DGX) stake by 79% in Q2 2026, selling an estimated $2.68M and leaving 3,663 shares worth $779K. The position accounts for 0.01% of the portfolio, ranked #253.

Manning & Napier Advisors first reported a position in DGX in Q1 2014 and has held it in 16 quarters since. The position peaked at $15M in Q1 2015. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Manning & Napier Advisors held 3,663 shares of Quest Diagnostics worth $779K as of Q2 2026.
  • Manning & Napier Advisors sold 13,633 Quest Diagnostics shares in Q2 2026, an estimated $2.68M.
  • Quest Diagnostics made up 0.01% of Manning & Napier Advisors's portfolio in Q2 2026, its #253 holding.
  • Manning & Napier Advisors first reported a position in Quest Diagnostics in Q1 2014 and has held it in 16 quarters since.
  • Manning & Napier Advisors's Quest Diagnostics position peaked at $15M in Q1 2015.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Manning & Napier Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.